Literature DB >> 30669135

Feasibility of MRI-only photon and proton dose calculations for pediatric patients with abdominal tumors.

Filipa Guerreiro1, Lauri Koivula, Enrica Seravalli, Geert O Janssens, John H Maduro, Charlotte L Brouwer, Erik W Korevaar, Antje C Knopf, Juha Korhonen, Bas W Raaymakers.   

Abstract

The purpose of this study was to develop a method enabling synthetic computed tomography (sCT) generation of the whole abdomen using magnetic resonance imaging (MRI) scans of pediatric patients with abdominal tumors. The proposed method relies on an automatic atlas-based segmentation of bone and lungs followed by an MRI intensity to synthetic Hounsfield unit conversion. Separate conversion algorithms were used for bone, lungs and soft-tissue. Rigidly registered CT and T2-weighted MR images of 30 patients in treatment position and with the same field of view were used for the evaluation of the atlas and the conversion algorithms. The dose calculation accuracy of the generated sCTs was verified for volumetric modulated arc therapy (VMAT) and pencil beam scanning (PBS). VMAT and PBS plans were robust optimized on an internal target volume (ITV) against a patient set-up uncertainty of 5 mm. Average differences between CT and sCT dose calculations for the ITV V 95% were 0.5% (min 0.0%; max 5.0%) and 0.0% (min  -0.1%; max 0.1%) for VMAT and PBS dose distributions, respectively. Average differences for the mean dose to the organs at risk were  <0.2% (min  -0.6%; max 1.2%) and  <0.2% (min  -2.0%; max 2.6%) for VMAT and PBS dose distributions, respectively. Results show that MRI-only photon and proton dose calculations are feasible for children with abdominal tumors.

Entities:  

Year:  2019        PMID: 30669135     DOI: 10.1088/1361-6560/ab0095

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  7 in total

Review 1.  Treatment planning for proton therapy: what is needed in the next 10 years?

Authors:  Hakan Nystrom; Maria Fuglsang Jensen; Petra Witt Nystrom
Journal:  Br J Radiol       Date:  2019-08-07       Impact factor: 3.039

Review 2.  Online daily adaptive proton therapy.

Authors:  Francesca Albertini; Michael Matter; Lena Nenoff; Ye Zhang; Antony Lomax
Journal:  Br J Radiol       Date:  2019-11-11       Impact factor: 3.039

Review 3.  Advances in radiotherapy technology for pediatric cancer patients and roles of medical physicists: COG and SIOP Europe perspectives.

Authors:  Chia-Ho Hua; Anthony E Mascia; Enrica Seravalli; Antony J Lomax; Klaus Seiersen; Kenneth Ulin
Journal:  Pediatr Blood Cancer       Date:  2021-05       Impact factor: 3.167

Review 4.  MR-guided proton therapy: a review and a preview.

Authors:  Aswin Hoffmann; Bradley Oborn; Maryam Moteabbed; Susu Yan; Thomas Bortfeld; Antje Knopf; Herman Fuchs; Dietmar Georg; Joao Seco; Maria Francesca Spadea; Oliver Jäkel; Christopher Kurz; Katia Parodi
Journal:  Radiat Oncol       Date:  2020-05-29       Impact factor: 3.481

5.  MRI-based treatment planning for proton radiotherapy: dosimetric validation of a deep learning-based liver synthetic CT generation method.

Authors:  Yingzi Liu; Yang Lei; Yinan Wang; Tonghe Wang; Lei Ren; Liyong Lin; Mark McDonald; Walter J Curran; Tian Liu; Jun Zhou; Xiaofeng Yang
Journal:  Phys Med Biol       Date:  2019-07-16       Impact factor: 3.609

Review 6.  Roadmap: proton therapy physics and biology.

Authors:  Harald Paganetti; Chris Beltran; Stefan Both; Lei Dong; Jacob Flanz; Keith Furutani; Clemens Grassberger; David R Grosshans; Antje-Christin Knopf; Johannes A Langendijk; Hakan Nystrom; Katia Parodi; Bas W Raaymakers; Christian Richter; Gabriel O Sawakuchi; Marco Schippers; Simona F Shaitelman; B K Kevin Teo; Jan Unkelbach; Patrick Wohlfahrt; Tony Lomax
Journal:  Phys Med Biol       Date:  2021-02-26       Impact factor: 4.174

7.  A technique to generate synthetic CT from MRI for abdominal radiotherapy.

Authors:  Shu-Hui Hsu; Pamela DuPre; Qi Peng; Wolfgang A Tomé
Journal:  J Appl Clin Med Phys       Date:  2020-02-11       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.